(Press-News.org) Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has confirmed. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.
The report is the first of a series that will probe more deeply into the nature of the change in these children's status. Having been diagnosed at one time with an autism spectrum disorder (ASD), these young people now appear to be on par with typically developing peers. The study team is continuing to analyze data on changes in brain function in these children and whether they have subtle residual social deficits. The team is also reviewing records on the types of interventions the children received, and to what extent they may have played a role in the transition.
"Although the diagnosis of autism is not usually lost over time, the findings suggest that there is a very wide range of possible outcomes," said NIMH Director Thomas R. Insel, M.D. "For an individual child, the outcome may be knowable only with time and after some years of intervention. Subsequent reports from this study should tell us more about the nature of autism and the role of therapy and other factors in the long term outcome for these children."
The study, led by Deborah Fein, Ph.D., at the University of Connecticut, Storrs, recruited 34 optimal outcome children, who had received a diagnosis of autism in early life and were now reportedly functioning no differently than their mainstream peers. For comparison, the 34 children were matched by age, sex, and nonverbal IQ with 44 children with high-functioning autism, and 34 typically developing peers. Participants ranged in age from 8 to 21 years old.
Prior studies had examined the possibility of a loss of diagnosis, but questions remained regarding the accuracy of the initial diagnosis, and whether children who ultimately appeared similar to their mainstream peers initially had a relatively mild form of autism. In this study, early diagnostic reports by clinicians with expertise in autism diagnosis were reviewed by the investigators. As a second step to ensure accuracy, a diagnostic expert, without knowledge of the child's current status, reviewed reports in which the earlier diagnosis had been deleted. The results suggested that children in the optimal outcome group had milder social deficits than the high functioning autism group in early childhood, but had other symptoms, related to communication and repetitive behavior, that were as severe as in the latter group.
The investigators evaluated the current status of the children using standard cognitive and observational tests and parent questionnaires. The optimal outcome children had to be in regular education classrooms with no special education services aimed at autism. They now showed no signs of problems with language, face recognition, communication, and social interaction.
This study cannot provide information on what percentage of children diagnosed with ASD might eventually lose the symptoms. Study investigators have collected a variety of information on the children, including structural and functional brain imaging data, psychiatric outcomes, and information on the therapies that the children received. Analysis of those data, which will be reported in subsequent papers, may shed light on questions such as whether the changes in diagnosis resulted from a normalizing of brain function, or if these children's brains were able to compensate for autism-related difficulties. The verbal IQs of the optimal outcome children were slightly higher than those with high functioning autism. Additional study may reveal whether IQ may have been a factor in the transition they made.
"All children with ASD are capable of making progress with intensive therapy, but with our current state of knowledge most do not achieve the kind of optimal outcome that we are studying," said Dr. Fein. "Our hope is that further research will help us better understand the mechanisms of change so that each child can have the best possible life."
###
Reference
Fein D, Barton M, Eigsti IM, Kelley, E, Naigles L, Schultz RT, Stevens M, Helt M, Orinstein A, Rosenthal M, Troyb E, Tyson K. Optimal outcome in individuals with a history of autism. Journal of Child Psychology and Psychiatry DOI: 10.111/jcpp.12037.
Project Number: R01 MH 076189
The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and cure. For more information, visit the http://www.nimh.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit the http://www.nih.gov.
Study documents that some children lose autism diagnosis
Small group with confirmed autism now on par with mainstream peers -- NIH-funded study
2013-01-15
ELSE PRESS RELEASES FROM THIS DATE:
Borderline personality disorder: The "perfect storm" of emotion dysregulation
2013-01-15
Philadelphia, PA, January 15, 2013 – Originally, the label "borderline personality disorder" was applied to patients who were thought to represent a middle ground between patients with neurotic and psychotic disorders. Increasingly, though, this area of research has focused on the heightened emotional reactivity observed in patients carrying this diagnosis, as well as the high rates with which they also meet diagnostic criteria for posttraumatic stress disorder and mood disorders.
New research now published in Biological Psychiatry from Dr. Anthony Ruocco at the University ...
Researchers create flexible, nanoscale 'bed of nails' for possible drug delivery
2013-01-15
Researchers at North Carolina State University have come up with a technique to embed needle-like carbon nanofibers in an elastic membrane, creating a flexible "bed of nails" on the nanoscale that opens the door to development of new drug-delivery systems.
The research community is interested in finding new ways to deliver precise doses of drugs to specific targets, such as regions of the brain. One idea is to create balloons embedded with nanoscale spikes that are coated with the relevant drug. Theoretically, the deflated balloon could be inserted into the target area ...
Lack of protein Sp2 disrupts neuron creation in brain
2013-01-15
A protein known as Sp2 is key to the proper creation of neurons from stem cells, according to researchers at North Carolina State University. Understanding how this protein works could enable scientists to "program" stem cells for regeneration, which has implications for neural therapies.
Troy Ghashghaei and Jon Horowitz, both faculty in NC State's Department of Molecular Biomedical Sciences and researchers in the Center for Comparative Medicine and Translational Research, wanted to know more about the function of Sp2, a cell cycle regulator that helps control how cells ...
Never forget a Face(book) -- memory for online posts beats faces and books
2013-01-15
People's memory for Facebook posts is strikingly stronger than their memory for human faces or sentences from books, according to a new study.
The findings shed light on how our memories favour natural, spontaneous writing over polished, edited content, and could have wider implications for the worlds of education, communications and advertising.
The research, authored by academics at the University of Warwick (Dr Laura Mickes) and UC San Diego (including Professors Christine Harris and Nicholas Christenfeld), tested memory for text taken from anonymised Facebook updates, ...
Facebook beats books - and faces - in memory test
2013-01-15
If this were a Facebook post, you would remember it – better than a stranger's face or a line from a published book.
That, in fewer than 140 characters, is the finding of research from the University of California, San Diego and the University of Warwick, published in the Springer journal Memory & Cognition.
Oh, and: The small, social-networking faux pas you were hoping would fade from your friends' memories real soon…? Don't count on it. Sorry. :/
In "Major Memory for Microblogs," the researchers report that Facebook status updates were about one and a half times ...
War was central to Europe's first civilization, contrary to popular belief
2013-01-15
Research from the University of Sheffield has discovered that the ancient civilisation of Crete, known as Minoan, had strong martial traditions, contradicting the commonly held view of Minoans as a peace-loving people.
The research, carried out by Dr Barry Molloy of the University of Sheffield's Department of Archaeology, investigated the Bronze Age people of Crete, known by many as the Minoans, who created the very first complex urban civilisation in Europe.
"Their world was uncovered just over a century ago, and was deemed to be a largely peaceful society," explained ...
Federal Supplemental Nutrition Assistance Program use grows in 2011
2013-01-15
DURHAM, N.H. – In 2011, 13 percent of all American households relied on the Supplemental Nutrition Assistance Program (SNAP) -- the program formerly known as food stamps – with nearly 6.2 million more American households using the program now than five years ago, according to new research from the Carsey Institute at the University of New Hampshire.
"The Great Recession had profound effects on families across the United States, and economic recovery has been slow. Poverty and unemployment remained high in 2011, and job growth was stagnant. Amid these signs of a sluggish ...
Researchers identify genetic mutation for rare cancer
2013-01-15
By looking at the entire DNA from this one patient's tumor, researchers have found a genetic anomaly that provides an important clue to improving how this cancer is diagnosed and treated.
Researchers at the University of Michigan Comprehensive Cancer Center sequenced the tumor's genome through a new program called MI-ONCOSEQ, which is designed to identify genetic mutations in tumors that might be targeted with new therapies being tested in clinical trials.
The sequencing also allows researchers to find new mutations. In this case, an unusual occurrence of two genes ...
A quantum leap in gene therapy of Duchenne muscular dystrophy
2013-01-15
COLUMBIA, Mo.-- Usually, results from a new study help scientists inch their way toward an answer whether they are battling a health problem or are on the verge of a technological breakthrough. Once in a while, those results give them a giant leap forward. In a preliminary study in a canine model of Duchenne muscular dystrophy (DMD), University of Missouri scientists showed exactly such a leap using gene therapy to treat muscular dystrophy. The results of the study will be published in the journal Molecular Therapy on Jan. 15, 2013.
Muscular dystrophy occurs when damaged ...
New path discovered for future generation of glucose-measuring biosensors
2013-01-15
CIC bioGUNE researchers have opened a new pathway for the future development of biosensors that enable measuring the glucose in the blood, but which are also believed to be more reliable with other fluids, such as urine. To this end, a complex scientific process has been developed which has called into question a dominant paradigm amongst the scientific community with respect to the mechanisms of binding and communication between proteins.
The mechanisms of communication at subcellular level are based on the interaction between proteins or between proteins and metabolites ...
LAST 30 PRESS RELEASES:
First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer
Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial
Higher blood pressure in childhood linked to earlier death from heart disease in adulthood
AI helped older adults report accurate blood pressure readings at home
High blood pressure in childhood and premature cardiovascular disease mortality
Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations
Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC
Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy
FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC
Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study
New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients
Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds
COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC
CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC
Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital
New medication lowered hard-to-control high blood pressure in people with chronic kidney disease
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
[Press-News.org] Study documents that some children lose autism diagnosisSmall group with confirmed autism now on par with mainstream peers -- NIH-funded study